My research centers on Synthetic Biology, a cutting-edge discipline where I meticulously engineer living organisms for revolutionary advancements in human health and industrial applications. Employing advanced techniques, I manipulate genetic components to design and optimize biological systems with precision. My primary interests lie in creating innovative solutions to human health challenges through the engineering of probiotics and other beneficial microbes, as well as developing industrially relevant organisms for the efficient production of valuable biomolecules.
Research Skills:
Soft Skills:
Problem-Solving:
Ability to troubleshoot experiments
Creative problem-solving in experimental design
Communication Skills:
Effectively communicating complex scientific concepts Writing research papers and reports
Collaboration:
Working in multidisciplinary teams collaboration with researchers from diverse backgrounds
Project Management:
Planning and executing research projects Meeting deadlines and milestones
1. Srivastava, S.K., Foo, G.W., Aggarwal, N., Chang, M.W., 2024. Organ-on-Chip Technology: Opportunities and Challenges in Biomedical Research. Biotechnology Notes( Review Accepted )
2. Dhyani, R., Srivastava, S.K., Shankar, K., Ghosh, T., Beniwal, A. and Navani, N.K., 2021. A chemical genetic approach using genetically encoded reporters to detect and assess the toxicity of plant secondary metabolites against bacterial pathogens. Journal of Hazardous Materials, 418, p.126399. [IF: 14.2]
3. Shaikh, A.A., Nothias, L.F., Srivastava, S.K., Dorrestein, P.C. and Tahlan, K., 2021. Specialized metabolites from ribosome engineered strains of Streptomyces clavuligerus. Metabolites, 11(4), p.239. [IF: 5.5]
4. Bhando, T., Bhattacharyya, T., Gaurav, A., Akhter, J., Saini, M., Gupta, V.K., Srivastava, S.K., Sen, H., Navani, N.K., Gupta, V. and Biswas, D., 2020. Antibacterial properties and in vivo efficacy of a novel nitrofuran, IITR06144, against MDR pathogens. Journal of Antimicrobial Chemotherapy, 75(2), pp.418-428. [IF: 5.7]
5. AbuSara, N.F., Piercey, B.M., Moore, M.A., Shaikh, A.A., Nothias, L.F., Srivastava, S.K., Cruz-Morales, P., Dorrestein, P.C., Barona-Gómez, F. and Tahlan, K., 2019. Comparative genomics and metabolomics analyses of clavulanic acid-producing Streptomyces species provides insight into specialized metabolism. Frontiers in Microbiology, 10, p.2550 [IF: 5.2]
6. Srivastava, S.K., King, K.S., AbuSara, N.F., Malayny, C.J., Piercey, B.M., Wilson, J.A. and Tahlan, K., 2019. In-vivo functional analysis of a class A β-lactamase-related protein essential for clavulanic acid biosynthesis in Streptomyces clavuligerus. PloS One, 14(4), p.e0215960 [IF: 3.7]
7. Ghosh, T., Srivastava, S.K., Gaurav, A., Kumar, A., Kumar, P., Yadav, A.S., Pathania, R. and Navani, N.K., 2019. A combination of linalool, vitamin C, and copper synergistically triggers reactive oxygen species and DNA damage and inhibits Salmonella enterica subsp. enterica Serovar Typhi and Vibrio fluvialis. Applied and Environmental Microbiology, 85(4) [Equal contribution] [IF: 5.0]
8. Bown, L., Srivastava, S.K., Piercey, B.M., McIsaac, C.K. and Tahlan, K., 2018. Mycobacterial membrane proteins QcrB and AtpE: roles in energetics, antibiotic targets, and associated mechanisms of resistance. The Journal of Membrane Biology, 251(1), pp.105-117 [Equal contribution] [IF: 2.4]
9. Gupta, S.K., Srivastava, S.K., Sharma, A., Nalage, V.H., Salvi, D., Kushwaha, H., Chitnis, N.B. and Shukla, P., 2017. Metabolic engineering of CHO cells for the development of a robust protein production platform. PloS One, 12(8), p.e0181455.. [Equal contribution] [IF: 3.7]
10. Srivastava, S.K., Iyer, V.R., Ghosh, T., Lambadi, P.R., Pathania, R. and Navani, N.K., 2016. Isolation of a non-genomic origin fluoroquinolone responsive regulatory element using a combinatorial bioengineering approach. Nucleic Acids Research,44(5), pp.2451-2461. [IF: 19.2]
11. Srivastava, S.K., Lambadi, P.R., Ghosh, T., Pathania, R. and Navani, N.K., 2014. Genetic regulation of spy gene expression in Escherichia coli in the presence of protein unfolding agent ethanol. Gene, 548(1), pp.142-148. [IF: 3.9]
12. Patil, S.D., Sharma, R., Srivastava, S.K., Navani, N.K. and Pathania, R., 2013. Downregulation of yidC in Escherichia coli by antisense RNA expression results in sensitization to antibacterial essential oils eugenol and carvacrol. PloS One, 8(3), p.e57370. [IF: 3.7]
13. Ghosh, I.N., Patil, S.D., Sharma, T.K., Srivastava, S.K., Pathania, R. and Navani, N.K., 2013. Synergistic action of cinnamaldehyde with silver nanoparticles against spore-forming bacteria: a case for judicious use of silver nanoparticles for antibacterial applications. International Journal of Nanomedicine, 8, p.4721. [IF: 7.0]
Aggarwal, N., Koh, E.W., Srivastava, S.K., Sieow, B.F. and Hwang, I.Y., 2022. Microbiome Engineering for Metabolic Disorders. Principles in Microbiome Engineering, pp.47-91.